Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
iShares Bitcoin Trust
IBIT
|
+$1.07B |
| 2 |
T-Mobile US
TMUS
|
+$1.01B |
| 3 |
Nasdaq
NDAQ
|
+$644M |
| 4 |
Columbia Research Enhanced Core ETF
RECS
|
+$612M |
| 5 |
Dell
DELL
|
+$527M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$1.99B |
| 2 |
NVIDIA
NVDA
|
+$1.26B |
| 3 |
iShares Silver Trust
SLV
|
+$809M |
| 4 |
Microsoft
MSFT
|
+$724M |
| 5 |
CRWV
CoreWeave, Inc. Class A Common Stock
CRWV
|
+$711M |
Sector Composition
| 1 | Technology | 18.93% |
| 2 | Financials | 9.8% |
| 3 | Consumer Discretionary | 8.69% |
| 4 | Industrials | 8.25% |
| 5 | Communication Services | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4951
LM Funding America
LMFA
$18.4M
| $70.4K | ﹤0.01% |
+24,609
| New | +$70.4K |
|
4952
Q32 Bio
QTTB
$21.8M
| $69.5K | ﹤0.01% |
+46,635
| New | +$69.5K |
|
4953
UNIFI
UFI
$84.6M
| $69.3K | ﹤0.01% |
13,273
+16
| +0.1% | +$84 |
|
4954
Relmada Therapeutics
RLMD
$53.1M
| $68.6K | ﹤0.01% |
+114,354
| New | +$68.6K |
|
4955
Enlivex Therapeutics
ENLV
$25.1M
| $68.4K | ﹤0.01% |
61,052
-19,707
| -24% | -$22.1K |
|
4956
Agilon Health
AGL
$472M
| $68.1K | ﹤0.01% |
+29,598
| New | +$68.1K |
|
4957
InnovAge Holding
INNV
$703M
| $67.6K | ﹤0.01% |
18,323
-28,504
| -61% | -$105K |
|
4958
Prime Medicine
PRME
$829M
| $67K | ﹤0.01% |
+27,145
| New | +$67K |
|
|
ARTV
4959
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$55.7M
| $66.8K | ﹤0.01% |
+44,215
| New | +$66.8K |
|
4960
Nine Energy Service
NINE
$29.7M
| $66.4K | ﹤0.01% |
86,058
+72,915
| +555% | +$56.2K |
|
4961
Maris-Tech
MTEK
$27.6M
| $66K | ﹤0.01% |
+20,619
| New | +$66K |
|
4962
DLH Holdings
DLHC
$80.3M
| $65K | ﹤0.01% |
+11,125
| New | +$65K |
|
4963
Big 5 Sporting Goods
BGFV
$32.8M
| $63.4K | ﹤0.01% |
+44,641
| New | +$63.4K |
|
|
CANG
4964
Cango
CANG
$808M
| $62.5K | ﹤0.01% |
+12,880
| New | +$62.5K |
|
4965
Milestone Pharmaceuticals
MIST
$165M
| $62K | ﹤0.01% |
+31,933
| New | +$62K |
|
4966
Telomir Pharmaceuticals
TELO
$45M
| $61.9K | ﹤0.01% |
+49,556
| New | +$61.9K |
|
|
HIX
4967
Western Asset High Income Fund II
HIX
$395M
| $61.5K | ﹤0.01% |
14,339
-936
| -6% | -$4.02K |
|
4968
AirSculpt Technologies
AIRS
$386M
| $60.4K | ﹤0.01% |
+12,509
| New | +$60.4K |
|
4969
Stagwell
STGW
$1.36B
| $60.4K | ﹤0.01% |
13,411
-109,589
| -89% | -$493K |
|
4970
FibroBiologics
FBLG
$22M
| $59.8K | ﹤0.01% |
+96,110
| New | +$59.8K |
|
4971
Solarmax Technology
SMXT
$58.1M
| $59.7K | ﹤0.01% |
+54,796
| New | +$59.7K |
|
|
GUT
4972
Gabelli Utility Trust
GUT
$522M
| $59.5K | ﹤0.01% |
+10,266
| New | +$59.5K |
|
|
CIK
4973
Credit Suisse Asset Management Income Fund
CIK
$163M
| $59.4K | ﹤0.01% |
+20,064
| New | +$59.4K |
|
4974
SKYX Platforms
SKYX
$140M
| $59.2K | ﹤0.01% |
56,612
-133,653
| -70% | -$140K |
|
4975
Carisma Therapeutics
CARM
$13.1M
| $59.1K | ﹤0.01% |
+150,810
| New | +$59.1K |
|